Sort
21,453 grants matching “tuberculosis”
Pharmacology and Pharmacometrics Core
$164,293Kelly E. Dooley · Johns Hopkins University · P30 · FY2022 · AI
Arf6 Inhibition as Novel Treatment for Multidrug Resistance Gram Negative Infections
$164,250Ashraf S. Ibrahim · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · R21 · FY2015 · AI
Re-evaluating the Duration in Children of TB Treatment (REDUCE TB): A Phase 2 Duration Randomized Trial
$164,241Anthony Joseph Garcia-Prats · University Of Wisconsin-Madison · U01 · FY2025 · AI
Virology, Next Generation Sequencing and Imaging Core E
$164,224David J McDonald · Case Western Reserve University · P30 · FY2015 · AI
Relapsing fever spirochete protein production within the vector
$164,125Job E Lopez · Mississippi State University · R21 · FY2013 · AI
A link between sleep-wake disturbances and enlarged perivascular spaces in youth with traumatic brain injury
$164,088Juan Andres Piantino · Oregon Health & Science University · K23 · FY2023 · HL
Tuberculosis case finding by oral swab PCR
$164,063Gerard A Cangelosi · University Of Washington · R21 · FY2016 · AI
Pharmacology of Antiretrovirals in Anatomical Brain Tissue among persons with chronic HIV infection
$164,023Melanie Rae Nicol · University Of Minnesota · R21 · FY2019 · NS
PRovide Options for Treatment of Exposed Children against Tuberculosis (PROTECT) Study
$164,000Yael R Hirsch-Moverman · Columbia University Health Sciences · R21 · FY2019 · AI
Improved Tools for Nontuberculous Mycobacteria Lung Disease
$163,990Keira Alexis Cohen · Johns Hopkins University · K08 · FY2022 · HL
Traditional Healers as Adherence Partners for PLHIV in Rural Mozambique
$163,984Carolyn Audet · Vanderbilt University Medical Center · K01 · FY2016 · MH
Clinical Pharmacology of Efavirenz Combined with High Dose Rifapentine
$163,848Anthony T Podany · University Of Nebraska Medical Center · K23 · FY2020 · AI
Traditional Healers as Adherence Partners for PLHIV in Rural Mozambique
$163,831Carolyn Audet · Vanderbilt University Medical Center · K01 · FY2017 · MH
Identifying novel antibiotics by targeting the EF-Tu complex formation
$163,816Juan Marugan · National Center For Advancing Translational Sciences · ZIA · FY2024 · TR
Clinical Core
$163,750Maunank Shah · Johns Hopkins University · P30 · FY2024 · AI
Ethics of Including Pregnant People in Clinical Trials
$163,750Petros C Karakousis · Johns Hopkins University · P30 · FY2024 · AI
Role of oxido-reductive stress in regulating HIV-TB coinfection
$163,702Roy L Sutliff · Emory University · R21 · FY2014 · AI
Training in Geographic Medicine and Infectious Diseases
$163,652James Walter Kazura · Case Western Reserve University · T32 · FY2014 · AI
DOT Selfie: A Mobile Health Intervention with Transfer of Social Bundle Incentives to Increase Treatment Adherence in Tuberculosis Patients in Uganda
$163,608Juliet Nabbuye Sekandi · University Of Georgia · R21 · FY2020 · TW
Short course therapy for MDR-TB based on PK/PD answers for biological variability
$163,538Tawanda Gumbo · Ut Southwestern Medical Center · R56 · FY2014 · AI
Collaborative:Elements:Cyberinfrastructure for Pedestrian Dynamics-Based Analysis of Infection Propagation Through Air Travel
$163,500Sirish Namilae · Embry-Riddle Aeronautical University · · FY2019 · CSE
Serial IGRA testing of Tanzanian adolescents to detect TB in household contacts
$163,324Maryam Amour · Muhimbili University/ Allied Hlth Scis · R21 · FY2023 · AI
Diabetes Evaluation in TB Patients in Eswatini for Improving TB/HIV Care and Treatment (DETECT) Study
$163,159Yael R Hirsch-Moverman · Columbia University Health Sciences · R21 · FY2022 · AI
Poor Treatment Response and Outcomes in Bedaquiline-Based Treatment Regimens for Drug-Resistant Tuberculosis in South Africa
$163,148Yuri F. Van Der Heijden · Vanderbilt University Medical Center · R01 · FY2025 · AI
Clinical Phenotyping: Pediatric HIV and TB Cohort
$163,041Gabriel Anabwani · Botswana Baylor Child/Clincal Ctr/Excell · U54 · FY2019 · AI